About this trial
The main aim of this prospective study is to analyze the survival rate of short-length implants (\<6.5 mm) in subjects with partial edentulism. Non-short length implant will be used as control arm. Additionally, others clinical parameters (marginal bone loss and prosthetic associated complications) will be measured.
Eligibility criteria
This trial does not accept healthy volunteersQualifiers
Age ≥ 18 years
Have planned a fixed multiple prosthesis supported by implants <6.5 mm in length and implants ≥ 6.5 mm in length within 15 days before the inclusion of the patient in the study.
Planning of supported prostheses from 2 to 4 implants dental
Have a previously performed CBCT (Cone Beam Computed Tomography)
Disqualifiers
Smokers> 10 cigarettes / day
Complete prostheses
Unitary prostheses
Trial population
Partial edentulism
Trial design
Cohort
Prospective
Treatments tested in this trial
BTI Implant
DeviceBTI Dental implants are non-active medical device, single use, non resterilizable, biocompatible and sterile devices made of alloplastic materials (Titanium) intended to be surgically implanted into alveolar and/or basal bone of the mandible or maxilla to provide support and a means of retention for a dental prosthesis (e.g. bridge, single-tooth, overdenture).
Treatment groups
Trial outcomes
Primary outcomes
Survival of dental implants
Survival of dental implants at one year post-implantation
Secondary outcomes
Marginal bone loss
Marginal bone loss at one year post-implantation
Incidence of prosthetic or implant complications
Sponsors and contacts
Click on the lead sponsor to view all of their trials.